---
title: "Weekly Recap | Guardant Health +13.98%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299511707.md"
description: "Guardant Health (GH.US) rose 13.98% this week to close at $179.38, outperforming the S&P 500 by about 14.06 percentage points. The week ran hot and cooled off: a strong push from $156.55 on Monday carried into Tuesday, and the stock touched a week high of $183.51 on Thursday before easing to $179.38 on Friday. The weekly range widened to 17.72%."
datetime: "2026-09-19T06:09:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299511707.md)
  - [en](https://longbridge.com/en/news/299511707.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299511707.md)
generator: "portal-rs"
---

# Weekly Recap | Guardant Health +13.98%, most brokers rate it buy

## The Week

Guardant Health (GH.US) rose 13.98% this week to close at $179.38, outperforming the S&P 500 by about 14.06 percentage points. The week ran hot and cooled off: a strong push from $156.55 on Monday carried into Tuesday, and the stock touched a week high of $183.51 on Thursday before easing to $179.38 on Friday. The weekly range widened to 17.72%.

## Key Events

The main company-specific thread was insider selling. CIO Kumud Kalia disposed of 4,000 shares on 15 September, and on 18 September a group of insiders sold more than $2.5m worth of stock, including director Tariq Musa and Steve Krognes. In the same week, Revere Asset Management bought 26,620 shares. A technical note on 16 September flagged a MACD golden cross, pointing to warmer momentum.

## Analyst Ratings

Across 28 covering firms, 21 rate the stock buy, 5 rate it overweight, 1 rates it underweight, and 1 has no opinion; there are no hold or sell ratings. The consensus is strong buy, with a target of $195.81, about 9.16% above the latest price. Targets are wide apart, from $225 to $105. GH ranks first among 53 names in the healthcare services industry.

## The Week Ahead

Macro data comes thick next week: Richmond Fed composite index on 22 September, two EIA inventory prints on 23 September, then jobless claims, current account balance, new home sales and natural gas storage on 24 September. There are no GH earnings or major company events on the calendar, so the main watch is how broad-market liquidity and sector sentiment feed into this name.

## In Short

GH rallied on higher volume this week while the analyst view stayed strong and the consensus target still sits above spot. But heavy insider selling and Friday’s pullback from the high create tension, and the latest daily money-flow snapshot shows large-lot flow is uneven. What matters next is whether insider selling continues, and whether next week’s macro prints support consolidation around this level.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [GH.US](https://longbridge.com/en/quote/GH.US.md)

## Related News & Research

- [How FDA Approval Has Changed The Investment Story At Guardant Health Stock](https://longbridge.com/en/news/299931120.md)
- [Steve Krognes Sells 6,674 Shares of Guardant Health (NASDAQ:GH) Stock](https://longbridge.com/en/news/299372118.md)
- [Apple (AAPL) Launches New Safeguards Against AI Agents](https://longbridge.com/en/news/300826528.md)
- [Sean Parker is rebuilding Stability AI around music](https://longbridge.com/en/news/300828548.md)
- [Piermont Valley Acquisition enters USD 5 million PIPE for Tigerless AI merger financing](https://longbridge.com/en/news/300825653.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**